ARIXTRA 2.5 MG / 0.5 ML

What is ARIXTRA?

ARIXTRA 2.5 MG / 0.5 ML contains FONDAPARINUX SODIUM : 2.5 MG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02245531, held by ASPEN PHARMACARE CANADA INC., supplied as SOLUTION for SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 10-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ARIXTRA used for?

ARIXTRA® (fondaparinux sodium, injection) is indicated for: Prophylaxis of venous thromboembolic events (VTE) for up to one month post-surgery in patients undergoing orthopedic surgeries of the lower limbs such as hip fracture, knee surgery or hip replacement surgery. Prophylaxis of venous thromboembolic events (VTE) in patients undergoing abdominal surgery who are at high risk of thromboembolic complications, such as patients undergoing abdominal cancer surgery. Treatment of Acute Deep Vein Thrombosis (DVT) and treatment of Acute Pulmonary Embolism (PE). Management of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) for the prevention of death and subsequent myocardial infarction. Management of ST segment elevation myocardial infarction (STEMI) for the prevention of death and myocardial reinfarction in patients who are managed with thrombolytics or who initially are to receive no form of reperfusion therapy.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

How is it stored and handled?

If ARIXTRA® is added to a 0.9% saline minibag it should be infused immediately, but can be stored between 15-30°C for up to 24 hours.

How is it supplied?

Package of 10: 2.5 mg ARIXTRA® in pre-filled 0.5 mL single use syringe, affixed with a 27-gauge x ½ inch needle with a blue plunger within a built-in automatic needle protection. 7.5 mg ARIXTRA® in 0.6 mL single use pre-filled syringe, affixed with a 27-gauge x ½ inch needle with a magenta plunger within a built-in automatic needle protection. 10 mg* ARIXTRA® in 0.8 mL single use pre-filled syringe, affixed with a 27-gauge x ½ inch needle with a violet plunger within a built-in automatic needle protection.

What can be used instead?

Other Canadian products sharing ATC code B01AX05 FONDAPARINUX. 4 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

Who else supplies FONDAPARINUX worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FONDAPARINUX appears in 32 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.